the heart rate thing is real enough that i mention it whenever someone asks about starting, happy to be corrected
#retatrutide 2026-02-14
- satiety_sig — GI was about the same as tirzepatide for me, the difference was how fast it arrived 14:01
- sol_sends — buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely 14:28
- retention_time — anyone compared their Medutest purity across two different SSA lots 15:29
- assay_low_al — the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial 16:32
stepping in 15 increments instead of doubling is the only thing i would change if i started again
glucagon is the new bit
anyone stayed at 1.7 for months rather than climbing
the half life supports weekly dosing and thats what ive done from the start
phase 2 was still trending at the end which is why the phase 3 readout matters more than usual
research use only is on every vial and i treat it as exactly that, nobody here is prescribing, n of 1 obviously
no long term data
sorry to jump in i said 9 months ago that my heart rate had settled and it has stayed settled since
watching my heart rate
phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
came off at 8 weeks because my resting rate stayed elevated and i didnt like it
GI was about the same as tirzepatide for me, the difference was how fast it arrived
mine went up too
stopped for 12 months and restarted at half my old dose, the ramp was easier second time
buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely
the purity spread across lots worries me more than the molecule does
coming back to this there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists
phase 2 only
does the energy expenditure claim show up as anything you can feel
appetite suppression at 10 was stronger than my tirzepatide experience at a comparable point
whats a sensible starting point, im seeing everything from 0.5 to 2
i log resting heart rate every morning because of this and its the one number i actually watch
held mine ages
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history
[edited]low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom
came off at 13 weeks because my resting rate stayed elevated and i didnt like it
anyone compared their Medutest purity across two different SSA lots
settled by month three
did the phase 2 result actually come in higher than the tirzepatide numbers
follow up is the GI worse than tirzepatide or about the same
TRIUMPH is phase 3
appetite suppression at 1 was stronger than my tirzepatide experience at a comparable point, still working it out
smaller steps here
the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial
blood pressure stayed flat for me while heart rate moved, which i didnt expect
my resting rate went up 9 bpm in the first month and came back most of the way by month 6
genuine question im at 1.7 and the appetite effect is stronger than i expected, normal
[edited]cant feel it honestly
quick one i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind, i think
nobody should read my log as a plan, im recording what i did and thats all it is
logging rhr daily
low and slow
is the glucagon arm what people mean by the energy expenditure thing
people insist on small steps because the side effects arrive faster than on the other two
triple agonist yeah
while im here back after 8 months, has anything actually been published since
is the phase 2 dosing anywhere near what people here run
[edited]*PeptideMeter not the other one